title: Persistent unilateral central serous chorioretinopathy in a breastfeeding woman.
abstract: A 40-year-old woman presented with blurred vision and floaters in her right eye for the past 7 months. The patient was in the sixth month of pregnancy at onset of the ocular symptoms and had persistent ocular disturbances postpartum. Her medical and ocular history were unremarkable except for LASIK surgery. Examination revealed an uncorrected visual acuity of 20/30 and 20/20 in the right and left eye, respectively. Fundus examination showed a round, subretinal exudate involving the foveal centre. Central serous chorioretinopathy was diagnosed by fluorescein angiogram and optical coherence tomography (OCT) showing foveal neurosensory detachment and treated with intravitreal bevacizumab. At her 4-month follow-up (8 month postpartum), OCT continued to show persistent foveal subretinal fluid. Patient declined further treatment and on follow-up 1 year later, still showed a persistent neurosensory detachment on OCT testing.
authors.affiliation: Department of Ophthalmology, Retinal Vascular Center, Houston, Texas, USA.
authors.forename: Christine Elizabeth
authors.initials: CE
authors.lastname: Lopez-Yang
authors.affiliation: Department of Ophthalmology, University of Texas Health Science Center at Houston, Houston, Texas, USA.
authors.forename: Charles A
authors.initials: CA
authors.lastname: Garcia
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D001942:Breast Feeding; D056833:Central Serous Chorioretinopathy / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D016896:Treatment Outcome; D016312:Treatment Refusal; D014786:Vision Disorders / Q000209:etiology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab